Nuveen, LLC Glaukos Corp Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Glaukos Corp stock. As of the latest transaction made, Nuveen, LLC holds 319,795 shares of GKOS stock, worth $27.8 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
319,795Holding current value
$27.8 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding GKOS
# of Institutions
344Shares Held
48.8MCall Options Held
270KPut Options Held
401K-
Black Rock Inc. New York, NY8.04MShares$698 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.97MShares$518 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.29MShares$199 Million0.04% of portfolio
-
State Street Corp Boston, MA2.06MShares$179 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.93MShares$168 Million0.08% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $4.13B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...